Psychedelics
Aaron Rodgers’ teammates appear to reference Packers QB’s ayahuasca use in TD celebration
Some of Aaron Rodgers’ teammates might have been paying attention to his very loud offseason. Near the end of the first half of “Sunday Night Football”…
Some of Aaron Rodgers’ teammates might have been paying attention to his very loud offseason.
Near the end of the first half of “Sunday Night Football” between the Green Bay Packers and Chicago Bears, the Packers quarterback found top returning receiver Allen Lazard for a four-yard touchdown pass.
As Lazard began his celebration, some members of the Packers offense — Randall Cobb, Aaron Jones, Jon Runyan, Yosh Nijman — grouped around him and mimed receiving something from the receiver, then playfully fell backward as though they were passing out.
As some Twitter users noted, it’s hard to not see the potential reference to Rodgers’ tales of hallucinogenic drugs last offseason:
Rodgers himself entered the impromptu huddle as some of his teammates flopped to the ground, but seemingly only to celebrate with Lazard as usual.
Rodgers made headlines during training camp when he recounted on a podcast how he took ayahuasca, a potent hallucinogen illegal in the United States, during a trip to Peru in the 2019 offseason. That drug use preceded back-to-back MVP seasons for Rodgers, which the quarterback claimed to not be a coincidence.
The admission triggered a miniature media circus (and massive spike in Google searches for ayahuasca), though it’s only another chapter in Rodgers’ recent habit of drawing attention for off-field reasons. At least his teammates are having fun with it.
The post Aaron Rodgers’ teammates appear to reference Packers QB’s ayahuasca use in TD celebration appeared first on REPORT DOOR.
ayahuasca hallucinogenic-
Psychedelics1 week ago
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
-
Psilocybin7 days ago
Are Shrooms Legal in Oregon: Full Guide
-
Law & Regulation1 week ago
Numinus reports declining revenue as the company restructures
-
Law & Regulation1 week ago
Going concern warnings cloud Xtacy Therapeutics’ shrunk losses
-
Psychedelics1 week ago
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
-
Psychedelics1 week ago
Psyence Group’s NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
-
Psychedelics7 days ago
Atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
-
Law & Regulation6 days ago
Clearmind signs agreement with Hebrew University for psychedelic compound rights